New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
07:33 EDTKMGKMG Chemicals reports Q2 EPS ex-items 12c vs. 18c last year
Reports Q2 revenue $84.3M vs. $56.96M last year. The company said, "The sales increase reflected the addition of the Ultra Pure Chemicals business, acquired in May 2013."
News For KMG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
08:34 EDTKMGKMG Chemicals now sees FY15 revenue $315M-$325M, one estimate $349.6M
The projected decline in fiscal 2015 sales reflects decreased sales in the Wood Treating Chemicals segment primarily due to the divestiture of the creosote business, partially offset by growth in the Electronic Chemicals segment. The Company continues to forecast that fiscal 2015 adjusted EBITDA will be $32-35 million. Adjusted EBITDA excludes the anticipated gain on the sale of the creosote business as well as restructuring and realignment charges previously disclosed.
08:34 EDTKMGKMG Chemicals sees gain of approx. $5.5M in Q2
Subscribe for More Information
08:34 EDTKMGKoppers Inc. acquires creosote distribution business of KMG Chemicals for $12.5M
Subscribe for More Information
08:33 EDTKMGKMG Chemicals announces sale of creosote distribution assets to Koppers
KMG Chemicals (KMG) announced that it has sold its creosote distribution business to Koppers Inc., a wholly-owned subsidiary of Koppers Holdings Inc. (KOP). Assets included in the transaction are KMG’s rail car and tank terminal leases, and creosote inventory. KMG estimates that cash proceeds from the sale will be approximately $15.5M, which includes approximately $3M worth of inventory. The asset sale closed concurrently with the signing of the asset purchase agreement. KMG fully retains its North American pentachlorophenol manufacturing operations, and the company will continue to produce and supply this important wood preservative used for the treatment of wooden utility poles and cross-arms.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use